At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

Adding the vaccine to treatment with Merck's Keytruda lowered melanoma patients' risk of ... With the exception of the ...

The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...

Last month, for the first time in two decades, a 6-year-old child in the U.S. died due to measles. Just a few weeks later, a ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

She has received honoraria paid to her personally for participation in advisory boards for Gilead Sciences, Merck ... But, ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...

Merck (NYSE:MRK) experienced a 13% increase in its stock price over the last month, aided by several significant developments. The company's upcoming presentations at the American College of ...